Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing—A Correlation Analysis Using Flurbiprofen as Probe Drug

  • Silvia Vogl,
  • Roman W. Lutz,
  • Gilbert Schönfelder,
  • Werner K. Lutz

There is an error in the third sentence of the second paragraph of the “Subjects and treatment” subsection of the Methods. The correct sentence is: According to the study design, which also designated phenotyping for CYP2D6, 10 mg dextromethorphan in water (DEX, as dextromethorphan hydrobromide monohydrate, Fagron, Barsbüttel, Germany) had been administered simultaneously.

Reference

  1. 1. Vogl S, Lutz RW, Schönfelder G, Lutz WK (2015) CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing—A Correlation Analysis Using Flurbiprofen as Probe Drug. PLoS ONE 10(3): e0120403. pmid:25775139

Citation: Vogl S, Lutz RW, Schönfelder G, Lutz WK (2015) Correction: CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing—A Correlation Analysis Using Flurbiprofen as Probe Drug. PLoS ONE 10(4): e0126329. https://doi.org/10.1371/journal.pone.0126329

Published: April 13, 2015

Copyright: © 2015 Vogl et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited